GE Healthcare and Oritain launch testing service to combat serum fraud

By Gareth Macdonald contact

- Last updated on GMT

Have you herd? Testing service cud help pharmas avoid serum fraud (iStock/tawatchaiprakobkit)
Have you herd? Testing service cud help pharmas avoid serum fraud (iStock/tawatchaiprakobkit)
Cell therapy firms will be able to authenticate the foetal bovie serum (FBS) they use through a testing programme launched by GE Healthcare and Oritain.

GE announced its partnership with testing services firm Oritain this week, explaining the idea is to help drug firms verify the origin of the FBS the use for culturing by comparing it with reference samples from low risk source countries, specifically New Zeland, the US and Australia.

Robert Curry, GE Healthcare senior product manager for cell culture serum, told us "Since FBS is derived from animals, the presence of virus and other infectious agents in serum is unavoidable and different countries of origin present different levels of risk of these agents being present.

"Consequently, the country of origin is of utmost priority“ ​he continued, adding "in addition, many manufactures have specific countries of origin written into their regulatory filing​. "

Serum fraud

Serum from low risk countries – those where the icidence of bovine illnesses like mad cow disease and foot and mouth is low – is more expensive than countries where such diseases are more common.

This price difference "opens the door for fraud​" according to Curry, who told us "to ensure that the raw sera are from the claimed origin, GE Healthcare has decided to put its sera products through a testing process that goes beyond industry standard practices​.”

He explained that Oritain analyzes samples from global sources to create a fingerprint of origin that GE can use for comparative purposes.

The fingerprints “cannot be changed or tampered with in any way without detection as we are dealing with concentrations in the parts per million across over 20 different variables​” Curry continued.

He went on to say the testing service will be available to all GE customers, explaining that: “We believe that all our customers will find this technology beneficial, but we envision this testing being a differentiator in Asia where serum fraud is more common​.”

Related news

Show more

Related products

show more

An Intense Focus on Perfusion

An Intense Focus on Perfusion

MilliporeSigma | 09-Oct-2017 | Technical / White Paper

Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion...

A Trusted Resin Provider For Over 35 Years

A Trusted Resin Provider For Over 35 Years

Purolite Life Sciences | 18-Sep-2017

Watch our video above to learn more about the history of Purolite Life Sciences.To discuss how we can assist your journey to process excellence, please...

The Next Stage – Eppendorfs new Mastercycler X50

The Next Stage – Eppendorfs new Mastercycler X50

Eppendorf for Bioprocess – Solutions that grow with you | 05-Sep-2017 | Application Note

The Mastercycler X50 is Eppendorf's new PCR cycler with lots of new benefits. Not only can you heat with 10°C/s, you can also optimize two different...

Related suppliers